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A cDNA encoding the complete precursor of the putative molt-inhibiting hormone (MIH) of the shore crab, Carcinus maenas, was isolated and 
sequenced. The precursor consists of a putative 35 amino acid signal peptide and the 78 amino acid mature MIH. The deduced MIH amino acid 
sequence is in complete agreement with the sequence previously determined by Edman degradation. I  situ hybridization revealed MIH-expression 
in a subpopulation f large neurosecretory perikarya of the medulla terminalis X-organ in the eyestalk. 
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1. INTRODUCTION 
The current consensus model regarding the control of 
molting in decapod crustaceans comprises the following 
tenets. The control is basically negative, i.e. there is a 
molt-inhibiting hormone (MIH) which keeps the animal 
in intermolt. It originates in the eyestalk ganglia, where 
it is produced by neurosecretory cells in the so-called 
medulla terminalis X-organ (MTXO). MIH is secreted 
from axon terminals in the sinus gland (SG), a neurohe- 
mal organ in the eyestalk. Inhibition of molting is 
thought o be due to a suppressive action of circulating 
MIH on ecdysteroid synthesis in the molting glands 
(Y-organs). The mechanism of this inhibitory action is 
not yet understood in detail (see [1-3] for reviews). 
Attempts to isolate and characterize MIH have con- 
sequently been based on bioassays in which the suppres- 
sion of ecdysteroid synthesis was measured. For the 
shore crab, Carcinus maenas, an efficient in vitro bioas- 
say, using isolated Y-organs, was developed [4] and 
proved useful for the isolation of a peptide with potent 
ecdysteroid synthesis-inhibiting activity from SG of this 
species [5]. The amino acid sequence of this putative 
MIH has recently been reported [6]. It is designated 
putative because its expected physiological in vivo role 
in the regulation of the natural molting cycle remains 
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to be demonstrated. The sequence of Carcinus MIH 
revealed similarity to a longer known peptide from the 
same species, the crustacean hyperglycemic hormone 
(CHH) [7] and to other MTXO peptides from different 
species. Together, they constitute a novel peptide family 
(CHH/MIH/VIH; see [8] for review). Carcinus MIH and 
CHH display a sequence homology of 28% and a lim- 
ited overlapping biological activity insofar as CHH has 
some MIH activity [5]. 
In order to study the genetic basis of both the intra- 
and interspecific relationship of the MTXO peptides, 
and thus their structural and functional divergence, in- 
vestigations on precursor structures by cDNA cloning 
are desirable. We have previously elucidated the com- 
plete structure of the Carcinus CHH precursor [9] and 
describe here the complete MIH precursor of this spe- 
cies by isolation of a full length clone from the same 
cDNA-library. 
2. MATERIALS AND METHODS 
2.1. Amplification of cDNA by the polymerase chain reaction (PCR ) 
To amplify cDNA encoding MIH, DNA of a previously generated 
library from MTXO neurosecretory cells of Carcinus maenas [9] served 
as template for the PCR. Two degenerated oligonucleotides, deduced 
from the amino acid sequence of Carcinus MIH [6] were used as 
primers (MI: 5"-GGGAATTC(C/A)G(A/C/G/T)GT(A/C/G/T)AT(T/ 
C/A)AA(T/C)GA(T/C)GA(A/G)TG(T/C)CC-3", sense, encoding amino 
acids 1 8 and M2: 5"-CCGGATCC(A/C/G/T)GC(A/C/G/T)CC(A/C/ 
G/T)A( A/G)( A/G/T)AT( A/C/GIT)CC( A/C/G/T)A CCC-3",antisense, en- 
coding amino acids 69-76 of MIH). The reaction was carried out for 
30 cycles with a denaturation step of 40 s at 93°C, an annealing step 
of 2 min at 60°C, and an extension step of 3 min at 72°C with a final 
extension of 7 min. PCR products were subcloned into pBluescript 
KS+ and sequenced. 
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178 CGCCTCCGTCACTCAGAGCTTGTGTGTGAGAGTCCTCCAAAGCGTC ATG ATG TCC 
MET-MET-Ser -  
I 
-35 
233 CGC GCT AAC TCC AGA TTT TCT  TGT CAG AGG ACG TGG CTG CTA TCG 
Arg -A la -Asn-Ser -Arg -Phe-Ser -Cys -G ln -Arg -Thr -T rp -Leu-Leu-Ser -  
-32 -18 
278 GTG GTG GTT CTG GCC GCC CTT TGG AGC TTC GGT GTC CAT CGA GCA 
Va l -Va l -Va l -Leu-A la -A la -Leu-Trp -Ser -Phe-G ly -Va l -H is -Arg -A la -  
SP  
-17 -3 
323 GCG GCG AGA GTT ATC AAC GAC GAG TGT CCA AAC CTT ATC GGC AAC 
A la -A la -Arg -Va l - I l e -Asn-Asp-G lu -Cys -Pro -Asn-Leu- I le -G ly -Asn-  
II 
-i 1 13 
368 AGA GAC CTT  TAT  AAG AAA GTA GAA TGG ATC TGC GAA GAC TGT TCA 
Arg -Asp-Leu-Tyr -Lys -Lys -Va l -G lu -Trp - I le -Cys -G lu -Asp-Cys -Ser -  
14 28 
413 AAC ATC TTC CGC AAG ACA GGA ATG GCG AGT CTC TGC AGA AGG AAC 
Asn- I le -Phe-Arg -Lys -Thr -G ly -MET-A la -Ser -Leu-Cys -Arg -Arg -Asn-  
M IH  
29 43 
458 TGC TTC TTT  AAC GAG GAC TTC GTG TGG TGT GTG CAC GCT ACC GAG 
Cys -Phe-Phe-Asn-G lu -Asp-Phe-Va l -T rp -Cys -Va l -H is -A la -Thr -G lu -  
44 58 
503 CGG TCC GAA GAG CTG AGA GAT TTG GAA GAG TGG GTT GGC ATT  CTT 
Arg -Ser -G lu -G lu -Leu-Arg -Asp-Leu-G lu -G lu -Trp -Va l -G ly - I le -Leu-  
59 73 
548 GGG GCT GGC CGG GAC TGA GCCTTGTCGTCTCTCCCTCCTTCATCATGGACGTC 
















1368 TACTG~T~CT~GTGATCTAC(A)  n 
Fig. hNucleotide-anddeducedaminoacid-sequen~ ofthecDNAencodingthe MIH precurs°r°fCarcmusmaenas'Thesequences°ftheputative 
signalpeptide(SP) andthe MIH areunderlined. Theputativepolyadenylationsiteis marked bybold-Neetype. 
2.2. PCR-based cDNA-library screening 
Based on the sequence data obtained from one clone (FRC7NP), 
a specific oligonucleotide (M3: 5'-TCCTTCTGCAGAGACTCGC-3", 
antisense, corresponding to bp 437-455 in Fig. 1) was designed and 
used in combination with primer M 1 for a PCR-based screening of the 
cDNA-library. DNA of the MTXO-cDNA-library, divided into 20 
batches, each containing 5000 independent clones, was used as tem- 
plate under the same conditions as described above. Batches which 
yielded an amplified product of the predicted length were subjected to 
cDNA-library screening by colony hybridization. 
2.3. Screening by colony hybridization 
Clones of two batches, selected according to the results of the 
PCR-based cDNA-library screening, were screened by colony hybrid- 
ization with a riP-labelled probe [11]. The probe was constructed by 
labelling the insert of clone FRC7NP with [nP]dATP by use of the 
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random priming technique [12,13]. Plasmid-DNA of positive clones 
was subcloned inpBluescript KS+ and sequenced on both strands. All 
sequences were determined by the dideoxy sequencing method [14]. 
2.4. In situ hybridization 
A RNA-probe was synthesized asrun-off transcript from linearized 
recombinant pBluescript II KS+ vectors including the cDNA se- 
quence between primers M 1 and M2 and labelled with digoxigenin-I 1 - 
dUTP  [15]. Optic ganglia from eyestalks of Carcinus maenas in inter- 
molt stage (C4) were dissected and immediately fixed in Bouin's fixa- 
tive for 16 h. After dehydration i ethanol series, fixed eyestalks were 
embedded in paraffin and 5-/.tm sections were collected on slides 
coated with 0.01% poly-e-lysine and baked overnight at 45-50°C. 
Mounted sections were deparaffinized and rehydrated. For hybridiza- 
tion of the specific MIH-mRNA the sections were pretreated with 
pepsin, rinsed in phosphate-buffered saline (PBS), postfixed, treated 
with hydroxylammonium chloride, finally rinsed in PBS, and dehy- 
drated. Hybridization was performed at 50°C for 16 h using digoxigen 
labelled cRNA probes at a concentration of 2 ng/gzl hybridization 
buffer. After washing of the slides and treatment with 50 pg/ml RNase 
A for 30 min at 37°C, visualization of the probe was performed as 
described by Tensen et al. [16]. 
3. RESULTS 
The clone whose sequence is shown in Fig. 1 was 
isolated from a cDNA library derived from neurosecre- 
tory MTXO cells of  Carc inus maenas  by a combination 
of  PCR-based screening and colony hybridization. It 
was sequenced in both directions, using specific ol- 
igonucleotides as primers. This clone consists of  a total 
of  1396 bp (excluding the poly(A) tail) and an open 
reading frame of  339 nucleotides. The open reading 
frame comprises the complete MIH  precursor sequence, 
consisting of  a signal peptide of  35 amino acid residues 
and the 78 residue mature MIH.  A Y-flanking sequence 
of 223 bp is present, as well as a 3'-untranslated region 
of  831 bp following the stop codon. 
Expression of  the MIH  gene was visualized in 
MTXO-per ikarya in the eyestalk of  Carc inus maenas  
(Fig. 2) by in situ hybridization with a digoxygenin 
labelled antisense cRNA probe, corresponding to bp 
329 555 of the cDNA clone (Fig. 1). 
4. D ISCUSSION 
The MIH  precursor of  Carc inus maenas  is a relatively 
simple one, consisting of  a signal peptide which is di- 
rectly followed by the MIH  sequence. The sequence of  
the hormone, as deduced here from the cDNA,  con- 
firms the sequence obtained previously by Edman deg- 
radation of  the mature peptide which was isolated from 
sinus glands [6]. 
Since MIH  has been recognized as a member of  a 
peptide family that also includes crustacean hyperglyce- 
mic hormones (CHH) and vitellogenesis-inhibiting 
hormone (VIH) (see [8] for review), the elucidation of  
the prohormone structure could be expected to yield 
more insights into the genetic relationship of  these pep- 
tides. In Carcinus,  two members of  the family are 
Fig. 2. Visualization of MIH-gene xpressing perikarya in the eyestalk 
ganglia of Carcinus maenas by in situ hybridization. MT, medulla 
terminalis neuropil; XO, X-organ; bar = 50 pm 
known, i.e. M IH  [6] and CHH [7]. The latter is a 72 
amino acid peptide while M IH  posesses 78 residues. A 
further difference is the presence of  both N-terminal 
and C-terminal blocking groups in CHH which are 
lacking in MIH.  Both peptides share 28% of  identical 
amino acid residues. 
The cDNA structure of  the CHH precursor has previ- 
ously been established in our laboratory [9]. Compari-  
son of  CHH and MIH  precursors reveals striking and 
interesting differences. In the CHH precursor, a 38- 
residue peptide and a dibasic processing site is encoded 
between the signal peptide and the CHH sequence. For 
this peptide, referred to as CHH precursor elated pep- 
tide (CPRP), no biological function has been found yet. 
Surprisingly, a sequence similar or homologous to 
CPRP is completely lacking in the MIH  precursor. 
The signal sequence of  the MIH  precursor is longer 
compared to that of  the CHH precursor (35 vs. 26 
amino acids). Another difference concerns the region 
preceding the stop codon: in the CHH precursor there 
is a Gly (as C-terminal amide donor) followed by Arg- 
Lys-Lys and the stop codon, whereas in the MIH  pre- 
cursor the codon for the last amino acid, Asp (which 
remains unamidated), is directly followed by the stop 
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codon. This difference may reflect the lack of  an amida- 
tion mechanism in the processing of  the MIH  precursor. 
In conclusion, comparison of  the MIH  and CHH 
precursor structures reveals a lower degree of  genetic 
relationship than could have been expected from the 
comparison of  the mature hormones. 
Clearly, more precursors of  CHH/MIH/V IH  peptides 
have to be elucidated before generalizations are possi- 
ble. A few further comments, however, appear to be 
warranted on the basis of  existing data. Comparison of  
known structures has revealed that Carcinus MIH is 
much more similar to V IH  of  Homarus than to CHH 
of  Carcinus or to any of  the other CHHs  which together 
form a highly homologous group; i.e. an MIH/V IH  type 
of  peptide appears to be clearly distinct from a CHH 
type [8]. The result of  the present study suggests that the 
distinction appears to be even more pronounced at the 
precursor level. To confirm this, it would be highly 
interesting to know the structure of  the V IH precursor. 
Although CHH precursors other than that of  Carcinus 
[9] have not yet been published, there is indirect evi- 
dence that they share structural characteristics, in par- 
ticular the presence of  CPRPs. Such peptides have been 
isolated and sequenced from the sinus glands of  four 
species [17]. They are homologous, and their stochio- 
metric relationship to the CHH peptides indicate that 
they are part of  the precursors. 
In situ hybridization reveals MIH-expression in a 
subpopulation of  the large neurosecretory MTXO peri- 
karya (Fig. 2). No  other MIH-expressing cells were ob- 
served in the entire eyestalk. These results agree with 
previous studies using peptide-immunocytochemistry 
[18]. In a separate paper we have studied the topograph- 
ical relationship of  M IH-  and CHH-gene-expressing 
perikarya in the MTXO in more detail [19]. 
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